Reducing waste: a guidelines-based approach to reducing inappropriate vitamin D and TSH testing in the inpatient rehabilitation setting.


Journal

BMJ open quality
ISSN: 2399-6641
Titre abrégé: BMJ Open Qual
Pays: England
ID NLM: 101710381

Informations de publication

Date de publication:
2019
Historique:
received: 27 02 2019
revised: 27 08 2019
accepted: 09 10 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 14 7 2020
Statut: epublish

Résumé

Laboratory overutilisation increases healthcare costs, and can lead to overdiagnosis, overtreatment and negative health outcomes. Discipline-specific guidelines do not support routine testing for Vitamin D and thyroid-stimulating hormone (TSH) in the inpatient rehabilitation setting, yet 94% of patients had Vitamin D and TSH tests on admission to inpatient rehabilitation at our institution. Our objective was to reduce Vitamin D and TSH testing by 25% on admission to inpatient Stroke, Spinal Cord Injury, Acquired Brain Injury and Amputee Rehabilitation units. A fishbone framework for root cause analysis revealed potential causes underlying overutilisation of Vitamin D and TSH testing. A series of Plan-Do-Study-Act (PDSA) cycles were introduced to target remediable factors, starting with an academic detailing intervention with key stakeholders that reviewed applicable clinical guidelines for each patient care discipline and the rationale for reducing admission testing. Simultaneously, computerised clinical decision support (CCDS) limited Vitamin D testing to specific criteria. Audit and feedback were used in a subsequent PDSA cycle. Frequency of Vitamin D and TSH testing on admission was the primary outcome measure. The number of electronic admission order caresets containing automatic Vitamin D and/or TSH orders before and after the interventions was the process measure. Rate of Vitamin D supplementation and changes in thyroid-related medication were the balancing measures. After implementation, 2.9% of patients had admission Vitamin D testing (97% relative reduction) and 53% of patients had admission TSH testing (43% relative reduction). Admission order caresets with prepopulated Vitamin D and TSH orders decreased from 100% (n=6) to 0%. The interventions were successful; similar to previous literature, CCDS was more effective than education and audit and feedback interventions alone. The interventions represent >$9000 annualised savings.

Sections du résumé

Background
Laboratory overutilisation increases healthcare costs, and can lead to overdiagnosis, overtreatment and negative health outcomes. Discipline-specific guidelines do not support routine testing for Vitamin D and thyroid-stimulating hormone (TSH) in the inpatient rehabilitation setting, yet 94% of patients had Vitamin D and TSH tests on admission to inpatient rehabilitation at our institution. Our objective was to reduce Vitamin D and TSH testing by 25% on admission to inpatient Stroke, Spinal Cord Injury, Acquired Brain Injury and Amputee Rehabilitation units.
Methods
A fishbone framework for root cause analysis revealed potential causes underlying overutilisation of Vitamin D and TSH testing. A series of Plan-Do-Study-Act (PDSA) cycles were introduced to target remediable factors, starting with an academic detailing intervention with key stakeholders that reviewed applicable clinical guidelines for each patient care discipline and the rationale for reducing admission testing. Simultaneously, computerised clinical decision support (CCDS) limited Vitamin D testing to specific criteria. Audit and feedback were used in a subsequent PDSA cycle. Frequency of Vitamin D and TSH testing on admission was the primary outcome measure. The number of electronic admission order caresets containing automatic Vitamin D and/or TSH orders before and after the interventions was the process measure. Rate of Vitamin D supplementation and changes in thyroid-related medication were the balancing measures.
Results
After implementation, 2.9% of patients had admission Vitamin D testing (97% relative reduction) and 53% of patients had admission TSH testing (43% relative reduction). Admission order caresets with prepopulated Vitamin D and TSH orders decreased from 100% (n=6) to 0%. The interventions were successful; similar to previous literature, CCDS was more effective than education and audit and feedback interventions alone. The interventions represent >$9000 annualised savings.

Identifiants

pubmed: 31750404
doi: 10.1136/bmjoq-2019-000674
pii: bmjoq-2019-000674
pmc: PMC6830472
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e000674

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ Open Qual. 2019 May 29;8(2):e000521
pubmed: 31206060
J Healthc Qual. 2001 Sep-Oct;23(5):4-14; quiz 14, 24
pubmed: 11565171
J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
pubmed: 21646368
Clin Chem Lab Med. 2015 Feb;53(2):157-83
pubmed: 25263310
Qual Saf Health Care. 2003 Feb;12(1):40-6
pubmed: 12571344
J Clin Endocrinol Metab. 2006 Jun;91(6):2105-11
pubmed: 16522687
Eur J Endocrinol. 2005 May;152(5):679-91
pubmed: 15879352
J Bone Miner Res. 2008 Sep;23(9):1449-57
pubmed: 18410229
J Rehabil Res Dev. 2008;45(1):15-29
pubmed: 18566923
Arch Phys Med Rehabil. 2004 Jan;85(1):59-64
pubmed: 14970969
J Hosp Med. 2014 Jan;9(1):13-8
pubmed: 24339375
BMJ Open Qual. 2017 Nov 06;6(2):e000212
pubmed: 29450304
J Hosp Med. 2015 Jun;10(6):390-5
pubmed: 25809958
Thyroid. 2014 Dec;24(12):1670-751
pubmed: 25266247
Qual Saf Health Care. 2003 Jun;12(3):215-20
pubmed: 12792013
Ann Intern Med. 2012 Jan 17;156(2):147-9
pubmed: 22250146
Br Med Bull. 2011;99:39-51
pubmed: 21893493
Ann Phys Rehabil Med. 2010 Dec;53(10):655-68
pubmed: 21094110
JAMA. 1998 Aug 12;280(6):550-8
pubmed: 9707147

Auteurs

Emma A Bateman (EA)

Physical Medicine & Rehabilitation, Western University, London, Ontario, Canada.

Alan Gob (A)

Medicine, London Health Sciences Centre, London, Ontario, Canada.

Ian Chin-Yee (I)

Pathology and Laboratory Medicine, London Health Sciences Centre, London, Ontario, Canada.

Heather M MacKenzie (HM)

Physical Medicine & Rehabilitation, Western University, London, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH